Literature DB >> 16774570

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection.

R Nir-Paz1, A Michael-Gayego, M Ron, C Block.   

Abstract

Eight commercially available tests for Mycoplasma pneumoniae (Serodia-Myco II, Labsystems IgM and IgG EIA, IgM and IgG LISA tests, ImmunoWell IgG test and SeroMP IgM and IgG) were compared using 204 single sera from healthy individuals. IgM peaked in late childhood and then declined, while IgG rose progressively into adulthood. Inter-assay agreement was poor. Positivity in Serodia-Myco II and LISA IgG was associated with blood group or Coombs positivity, suggesting non-specific reactions. The study confirmed that single serum serology is unsuitable for the diagnosis of M. pneumoniae infection, and that commercially available tests need further improvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16774570     DOI: 10.1111/j.1469-0691.2006.01469.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  22 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.

Authors:  Seema Jain; Wesley H Self; Richard G Wunderink; Sherene Fakhran; Robert Balk; Anna M Bramley; Carrie Reed; Carlos G Grijalva; Evan J Anderson; D Mark Courtney; James D Chappell; Chao Qi; Eric M Hart; Frank Carroll; Christopher Trabue; Helen K Donnelly; Derek J Williams; Yuwei Zhu; Sandra R Arnold; Krow Ampofo; Grant W Waterer; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-07-14       Impact factor: 91.245

Review 3.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China.

Authors:  Changying Lin; Shaoli Li; Hongmei Sun; Hanqing Zhao; Yanling Feng; Ling Cao; Yi Yuan; Ting Zhang
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

5.  Mycoplasma pneumoniae: Innocent Bystander or a True Cause of Central Nervous System Disease?

Authors:  Ari Bitnun; Susan E Richardson
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

6.  Distribution of Mycoplasma pneumoniae and Mycoplasma salivarium in the synovial fluid of arthritis patients.

Authors:  Sheena M Johnson; Felix Bruckner; David Collins
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

7.  Binding of IgA by Mycoplasma penetrans.

Authors:  Awni Moussa; Ran Nir-Paz; Shlomo Rottem
Journal:  Curr Microbiol       Date:  2009-02-03       Impact factor: 2.188

8.  Evaluation of IgM Lateral Flow Assay as a Screening Tool for Mycoplasma pneumoniae Infection in Childhood Pneumonia.

Authors:  Patrick M Meyer Sauteur; Elena Pánisová; Lucas M Bachmann; Lilliam Ambroggio; Christoph Berger
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

9.  Laboratory diagnosis of Mycoplasma pneumoniae respiratory tract infections in children.

Authors:  E Souliou; M Almasri; A Papa; A Theodoridou; E Diza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06-07       Impact factor: 5.103

10.  High seroprevalence of Mycoplasma pneumoniae IgM in acute Q fever by enzyme-linked immunosorbent assay (ELISA).

Authors:  Chung-Hsu Lai; Lin-Li Chang; Jiun-Nong Lin; Wei-Fang Chen; Li-Li Kuo; Hsi-Hsun Lin; Yen-Hsu Chen
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.